CELECOXIB

Clinical Indication

Inflammatory pain associated with cancer or other palliative conditions

Date of classification

November 2019

Review date

November 2019

Amber SIMPLE

Drugs suitable to be initiated and prescribed in primary care only after specialist assessment and recommendation. A shared care agreement is not required.